Mice treated with LR17 had decreased sepsis severity demonstrated by lower levels of IL-6, TNF-a, and IL-10 in serum, peritoneal and bronchoalveolar fluid, and IL-6 and TNF-a in the liver, and lung (23). This evidence concerns the gene IL10 and Sepsis.